Ex-Allergan leader joins BioMarin board; Ex-FDA official Dr. Goodman joins GSK board; Dr. Reddy's relaunches generic Nexium in a new color;

> Former Allergan CEO David Pyott has joined BioMarin's board of directors. Report

> GlaxoSmithKline has named former FDA chief scientist Dr. Jesse Goodman to its board of directors. Release

> NHS has decided to return to its original recommendation that Merck's Ezetrol (Zetia) be used for treating primary hypercholesterolemia in some adults. Story

> Dr. Reddy's Laboratories has relaunched its generic version of AstraZeneca heartburn med Nexium after a U.S. court made it stop using the color purple. Story

Suggested Articles

Late-stage ovarian cancer patients have few options, but now the FDA is reviewing GSK's Zejula for the patient group.

The FDA has raised questions about the manufacturing of Glenmark's new molecular entity Ryaltris, a nasal spray for seasonal allergic rhinitis.

Despite unconventional support from President Donald Trump, Johnson & Johnson’s Spravato didn’t win broad backing at the VA.